184 related articles for article (PubMed ID: 26817878)
1. Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis: Correlations With Detailed Pathological Findings.
Ko ES; Kim JH; Lim Y; Han BK; Cho EY; Nam SJ
Medicine (Baltimore); 2016 Jan; 95(3):e2453. PubMed ID: 26817878
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes.
Kim JH; Ko ES; Lim Y; Lee KS; Han BK; Ko EY; Hahn SY; Nam SJ
Radiology; 2017 Mar; 282(3):665-675. PubMed ID: 27700229
[TBL] [Abstract][Full Text] [Related]
3. Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy.
Parikh J; Selmi M; Charles-Edwards G; Glendenning J; Ganeshan B; Verma H; Mansi J; Harries M; Tutt A; Goh V
Radiology; 2014 Jul; 272(1):100-12. PubMed ID: 24654970
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity.
Heacock L; Melsaether AN; Heller SL; Gao Y; Pysarenko KM; Babb JS; Kim SG; Moy L
Eur J Radiol; 2016 Apr; 85(4):815-23. PubMed ID: 26971429
[TBL] [Abstract][Full Text] [Related]
5. MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
Holli-Helenius K; Salminen A; Rinta-Kiikka I; Koskivuo I; Brück N; Boström P; Parkkola R
BMC Med Imaging; 2017 Dec; 17(1):69. PubMed ID: 29284425
[TBL] [Abstract][Full Text] [Related]
6. Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.
He X; Zhou J; Ye S; Cheng Q; Miao H; Xu N; Li J; Pan Z; Cheng J; Wang M
Clin Radiol; 2021 Jun; 76(6):470.e13-470.e22. PubMed ID: 33648758
[TBL] [Abstract][Full Text] [Related]
7. The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
Clin Breast Cancer; 2016 Dec; 16(6):e145-e152. PubMed ID: 27566960
[TBL] [Abstract][Full Text] [Related]
8. Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients.
Kamiya S; Satake H; Hayashi Y; Ishigaki S; Ito R; Kawamura M; Taoka T; Iwano S; Naganawa S
Breast Cancer; 2022 Jan; 29(1):164-173. PubMed ID: 34529241
[TBL] [Abstract][Full Text] [Related]
9. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
10. Reducing metallic artifacts in postoperative spinal imaging: usefulness of IDEAL contrast-enhanced T1- and T2-weighted MR imaging--phantom and clinical studies.
Cha JG; Jin W; Lee MH; Kim DH; Park JS; Shin WH; Yi BH
Radiology; 2011 Jun; 259(3):885-93. PubMed ID: 21386053
[TBL] [Abstract][Full Text] [Related]
11. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
12. Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer.
Hahn SY; Ko ES; Han BK; Lim Y; Gu S; Ko EY
Medicine (Baltimore); 2016 Jul; 95(27):e4086. PubMed ID: 27399100
[TBL] [Abstract][Full Text] [Related]
13. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors.
Park MJ; Cha ES; Kang BJ; Ihn YK; Baik JH
Korean J Radiol; 2007; 8(5):390-6. PubMed ID: 17923781
[TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images.
Utsunomiya D; Notsute S; Hayashida Y; Lwakatare F; Katabuchi H; Okamura H; Awai K; Yamashita Y
AJR Am J Roentgenol; 2004 Feb; 182(2):399-404. PubMed ID: 14736670
[TBL] [Abstract][Full Text] [Related]
15. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
[TBL] [Abstract][Full Text] [Related]
16. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis.
Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH
J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761
[TBL] [Abstract][Full Text] [Related]
17. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
18. Combined use of T2-weighted MRI and T1-weighted dynamic contrast-enhanced MRI in the automated analysis of breast lesions.
Bhooshan N; Giger M; Lan L; Li H; Marquez A; Shimauchi A; Newstead GM
Magn Reson Med; 2011 Aug; 66(2):555-64. PubMed ID: 21523818
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of thymic epithelial tumors.
Kushihashi T; Fujisawa H; Munechika H
Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
[TBL] [Abstract][Full Text] [Related]
20. Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma.
Akita A; Shinmoto H; Hayashi S; Akita H; Fujii T; Mikami S; Tanimoto A; Kuribayashi S
Eur Radiol; 2011 Sep; 21(9):1850-7. PubMed ID: 21479769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
